Eurus Lifesciences Llp Profile
Key Indicators
- Obligation of Contribution ₹ 0.30 M
- Company Age 7 Year, 1 Month
- Last Filing with ROC 31 Mar 2023
- Revenue Growth 249.38%
- Profit Growth 1162.10%
- Ebitda 127.04%
- Total Assets -29.11%
About Eurus Lifesciences Llp
Eurus Lifesciences Llp (ELL) is 7 Year, 1 Month old Limited Liability Partnership 08 December 2017. Its registered office is in Ahmedabad, Gujarat, India.
The LLP status is Active, and it has filed its Accounts and Solvency Statement up to 31 Mar 2023 (FY 2022-2023). It's Total Obligation of Contribution is Rs 0.30 M as per MCA.
Company Details
-
Location
Ahmedabad, Gujarat, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN/FCRN
AAL-3529
-
Incorporation Date
08 Dec 2017
-
Date of Accounts and Solvency Statement
31 Mar 2023
-
ROC Code
Roc-Ahmedabad
-
Company Classification
Limited Liability Partnership
Industry
Who are the key members and board of directors at Eurus Lifesciences Llp?
Designated Partners (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Ullasbhai Shah
|
Designated Partner | 08-Dec-2017 | Current |
|
Bhavik Jain
|
Designated Partner | 08-Dec-2017 | Current |
|
Viral Shah
|
Designated Partner | 08-Dec-2017 | Current |
Financial Performance of Eurus Lifesciences Llp.
Eurus Lifesciences Llp, for the financial year ended 2021, experienced significant growth in revenue, with a 249.38% increase. The company also saw a substantial improvement in profitability, with a 1162.1% increase in profit. The company's net worth witnessed no change by increase of 0%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Eurus Lifesciences Llp?
Unlock access to Eurus Lifesciences Llp's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
-
Gelmek Healthcare Private LimitedBhavik Jain is a mutual person
-
Fitwel Pharmaceuticals Private LimitedBhavik Jain is a mutual person
-
Carewell Global Labs Private LimitedUllasbhai Shah and Viral Shah are mutual person
-
Meghvarsha Securities Private Limited
Ullasbhai Shah is a mutual person
-
Euraphor Lifesciences Private Limited
Bhavik Jain and Viral Shah are mutual person
-
Bandhu Urban Technologies India Private Limited
Viral Shah is a mutual person
Charges (Loans)
There are no Open Charges registered against the LLP as per our records.
How Many Employees Work at Eurus Lifesciences Llp?
Unlock and access historical data on people associated with Eurus Lifesciences Llp, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Eurus Lifesciences Llp, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Eurus Lifesciences Llp's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.